IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
714.10
-3.37 (-0.47%)
At close: Dec 5, 2025, 4:00 PM EST
710.02
-4.08 (-0.57%)
After-hours: Dec 5, 2025, 5:34 PM EST
IDEXX Laboratories Stock Forecast
Stock Price Forecast
According to 9 professional analysts, the 12-month price target for IDEXX Laboratories stock ranges from a low of $475 to a high of $830. The average analyst price target of $683.89 forecasts a -4.23% decrease in the stock price over the next year.
Price Target: $683.89 (-4.23%)
Analyst Consensus: Buy
* Price targets were last updated on Nov 4, 2025.
Analyst Ratings
The average analyst rating for IDEXX Laboratories stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 1 | 2 | 2 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 8 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $765 → $805 | Buy | Maintains | $765 → $805 | +12.73% | Nov 4, 2025 |
| UBS | UBS | Hold Maintains $710 → $750 | Hold | Maintains | $710 → $750 | +5.03% | Nov 4, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $675 → $775 | Buy | Maintains | $675 → $775 | +8.53% | Nov 4, 2025 |
| BTIG | BTIG | Strong Buy Maintains $785 → $830 | Strong Buy | Maintains | $785 → $830 | +16.23% | Nov 4, 2025 |
| Stifel | Stifel | Hold → Strong Buy Upgrades $640 → $700 | Hold → Strong Buy | Upgrades | $640 → $700 | -1.97% | Oct 31, 2025 |
Financial Forecast
Revenue This Year
4.37B
from 3.90B
Increased by 12.15%
Revenue Next Year
4.76B
from 4.37B
Increased by 8.79%
EPS This Year
13.15
from 10.67
Increased by 23.29%
EPS Next Year
14.73
from 13.15
Increased by 11.98%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 4.5B | 5.0B | ||||
| Avg | 4.4B | 4.8B | ||||
| Low | 4.2B | 4.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 15.7% | 13.3% | ||||
| Avg | 12.1% | 8.8% | ||||
| Low | 7.6% | 3.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 13.65 | 15.72 | ||||
| Avg | 13.15 | 14.73 | ||||
| Low | 12.21 | 13.90 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 27.9% | 19.5% | ||||
| Avg | 23.3% | 12.0% | ||||
| Low | 14.4% | 5.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.